Navigation Links
Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
Date:9/10/2007

With 30 Installed Inveon Imaging Systems, Siemens Medical Solutions Solidifies Its Market-Leading Position in Preclinical Imaging Centers

HOFFMAN ESTATES, Ill., Sept. 10 /PRNewswire-FirstCall/ -- The old adage says "a picture is worth 1,000 words," but that value is undoubtedly higher in preclinical research where high-resolution images can validate years of work. Siemens Medical Solutions, Molecular Imaging division (http://www.usa.siemens.com/medical), manufacturer of the Inveon(TM) preclinical imaging system, continues to lead the preclinical imaging market, through a strong investment in its research partners and through the demand for the versatile and upgradeable Inveon platform.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

The Inveon is a modular system that allows users to combine positron emission tomography (PET), single photon emission computed tomography (SPECT) and computed tomography (CT) acquisition systems in one unit. The system also delivers the industry's highest PET resolution and sensitivity and it boasts a suite of research tools that improve the workflow of basic research. These tools can help speed the drug development process as they enable researchers to identify specific biological processes, monitor the efficacy of compounds, and measure the effects of disease progression over time.

Thirty Installed Systems

Siemens will install the 30th Inveon preclinical imaging system at The Methodist Hospital in Houston. The collaboration between Siemens and The Methodist Hospital was well-timed as Radiology Department Chairman, King Li, MD, FRCP, MBA, has led the department on a major commitment to establish research as an institutional priority. As such, The Methodist Hospital is experiencing a period of unprecedented growth and it has created
'/>"/>

SOURCE Siemens Medical Solutions
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
3. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
4. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
7. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
8. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
9. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
10. Metabasis Therapeutics Presents Results of Preclinical Studies for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia, at the Endocrine Societys Annual Meeting
11. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/27/2008)...ec. 23 Warner Chilcott L...of its subsidiaries and Mayne Pharma International...., have filed lawsuits against each of Mutual Phar...euticals Inc. ("Mylan") and Impax Laboratories, In...ct of New Jersey for infringement of Mayne,s U.S. ...
(Date:12/17/2008)...n development and validation of non-animal alterna...17 MatTek Corporation today announ...ESAC) endorsed the scientific validity of the Modi...ember meeting. ESAC concluded that the Modified E... for the prediction of skin irritating and non-irr...
(Date:12/17/2008)... PEAK Surgical, Inc., a medical,de...ction system based on a,proprietary technology, a...stration (FDA) has granted the company 510(k) clea...tting and coagulation of soft tissue during,plast... gynecologic,orthopedic, arthroscopic, spinal an...
(Date:12/17/2008)...e, December 17 NicOx,S....tive results of a,pre-specified pooled analysis o...e 301, 302 and 303 pivotal phase 3 studies for nap...ificant reduction in systolic and diastolic blood,...g bid over the whole 13 week,period (p<0.001 f...
Breaking Medicine Technology:Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 2Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent 3EpiDerm's Skin Irritation Test Fully Validated in European Union 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 2NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 3NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 4NicOx' Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis 5June GEOSPHERE media highlights 3472 1June GEOSPHERE media highlights 3472 2June GEOSPHERE media highlights 3472 3June GEOSPHERE media highlights 3472 4Inflammation depression and antidepressant response 3A Common mechanisms 20582 1OHSU Cancer Institute researchers find many stomach cancer patients are not gertting best therapy 20578 1OHSU Cancer Institute researchers find many stomach cancer patients are not gertting best therapy 20578 2Certain Tests in ERs Raise Cancer Risk for Some 20575 1Certain Tests in ERs Raise Cancer Risk for Some 20575 2Certain Tests in ERs Raise Cancer Risk for Some 20575 3Certain Tests in ERs Raise Cancer Risk for Some 20575 4
(Date:1/8/2009)..., NEW YORK, Jan. 8 New York City ...9 "IBREA Brain Education Day" and presented a proc...tional Brain Education Association) and developer ...itive training to enhance health, well-being, and ...ognized thought leader regarding the power of indi...
(Date:1/8/2009)..., ALEXANDRIA, Va., Jan. 8 /PRNewswire-USNewswire/...e Organization along with several national leaders...arding the principles of hospice care and protecti...ons standing together in sharing this unified mess...ation of Hospice and Palliative Medicine, Hospice ...
(Date:1/8/2009)... Molecules of sugar sitting on the surface of canc...ine aimed at both treating and stopping the spread...ich include prostate, breast, ovarian and lung, am...600,000 from the Gateway for Cancer Research, an I...st Alessandra Franco, M.D., Ph.D., and her co-work...
(Date:1/8/2009)..., New Allscripts Prenatal Solution Key Factor in ... CHICAGO and ORLANDO, Fla., Jan. 8 /PRNewswire-Fir...an Associates LLC, one of the largest multi-specia..., has selected the Allscripts Enterprise(TM) Elect...their 80 physicians in 18 offices across Central F...
Breaking Medicine News(10 mins):Health News:NYC Mayor Michael R. Bloomberg Declares January 8th 'IBREA Brain Education Day' 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4
... implementing polio eradication strategies during ...ery and rehabilitation of polio victims. // "The ...pproved funds of Rs.10.39 billion for implementing...ear 2006-07," Information and Broadcasting Ministe...
...n the capital last year with, experts said Wednesd..., the same number of female foetuses were aborted ...ine expert, quoting records of the Delhi governmen...ltrasound clinics based on three months data, we f...
...ich held promise for being the best in the heap wi...he main objective of lowering the rate of the dise... The project has also overshot the budget and turn...not get the estimated participation, and was unabl...
...ditation and relaxation techniques, have proved be...hers at the University of Illinois says//. Adding...Martial arts such as Qigong and Taiji, practiced b...ial health benefits to older adults. Qigong (chee...
Other Medicine News:Health News:Older Adults could be Benefited from Chinese Martial-Arts 2Health News:Older Adults could be Benefited from Chinese Martial-Arts 3Health News:Older Adults could be Benefited from Chinese Martial-Arts 4
John weiss, wright acrylic globe.
Guthrie fixation hook, sharp double prongs.
Joseph Double Hook 10 mm wide. Designated most popular model or size.
Freer skin hook with blunt double prongs.
Medicine Products: